Biological characterization of mouse erythroblastic leukemia cells in haploiden tical mice.
- Author:
Lian-Ning DUAN
1
;
Kun-Yuan GUO
;
Jian-Xin CHU
;
Shun-Li DING
Author Information
1. Department of hematology, Zhujiang Hospital, The First Military Medical University, Guangzhou 510282, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Cell Division;
Disease Models, Animal;
H-2 Antigens;
analysis;
Leukemia, Erythroblastic, Acute;
immunology;
pathology;
Mice;
Mice, Inbred BALB C;
Mice, Inbred C57BL;
Mice, Inbred Strains;
Neoplasm Transplantation;
Survival Analysis;
Tumor Cells, Cultured
- From:
Journal of Experimental Hematology
2002;10(3):218-221
- CountryChina
- Language:Chinese
-
Abstract:
Using transplantable erythroblastic leukemia cells of EL9611(H-2d), the cells were inoculated to CB6F(1)(H-2d/b) generation of BALB/c x C57BL/6 mouse, the biological characterization of erythroblastic leukemia in haploidentical mouse was studied, that provides an experimental model for the study of graft-versus leukemia (GVL) with bone marrow or stem cell transplantation. When 10(3) - 10(8) of the spleen cells of EL9611(H-2d) had been intravenously inoculated to CB6F(1) mouse, the erythroblastic leukemia cells were transplanted successively and the F(1) generation of erythroblastic leukemia model in mice was established with 100% incidence of erythroblastic leukemia. There was a linear relationship between the survival time and the number of leukemic cell. The survival time of the mice was (9.6 +/- 0.8) days when 10(6) cells were inoculated. If the CB6F(1) mouse was transplanted successively for four generations, the incidence was 100%. The main targets for the leukemic EL9611(H-2d) cells were liver, spleen and marrow. The reaction of the erythroblastic leukemia cells for hemoglobin staining was positive, while the peroxidase reaction was negative. These cells were sensitive to some chemotherapeutic drugs, such as cytosine arabinoside and cyclophosphamide. This study presents the convenience for the studies on the GVL with haplo-allogeneic transplantation, in the F(1) generation of erythroblastic leukemia model of the commonly-used CD57BL/6 x BALB/c mouse.
